Your feedback is important to us!
We invite all our readers to share with us their views and comments about this article.
Disclaimer: Comments submitted by third parties on this site are the sole responsibility of the individual(s) whose content is submitted. The Daily Star accepts no responsibility for the content of comment(s), including, without limitation, any error, omission or inaccuracy therein. Please note that your email address will NOT appear on the site.
Alert: If you are facing problems with posting comments, please note that you must verify your email with Disqus prior to posting a comment. follow this link to make sure your account meets the requirements. (http://bit.ly/vDisqus)
To mark the second anniversary of the British government's Review on Antimicrobial Resistance (AMR), which I had the honor of chairing, two members of the review team – Anthony McDonnell and Will Hall – and I have published a new book: "Superbugs: An Arms Race Against Bacteria". In it, we discuss the review's 10 recommended interventions – what I call the Ten Commandments – while considering the progress made so far and the work that still needs to be done.The progress made in these two areas gives me hope that similar advances can be made elsewhere.But further progress will require less talk and more action from government and industry leaders.The largest 25 firms could easily persuade key governments to act on the review's recommendation for a market-entry reward.That points to the need for governments to do more as well. Following the review, AMR was finally put on the G-20's agenda, both at the 2016 summit in Hangzhou, China, and at last year's summit in Hamburg, Germany.A market-entry reward is crucial because it would also help to advance two of the review's six "demand-reducing" interventions: the development of new vaccines and improved diagnostics.
The global economy 10 years after the 2008 crisis
The Turkish emerging-market time bomb
The G-7, an ancient relic
of a bygone era
FOLLOW THIS ARTICLE